Financing | Polyneuron Pharmaceuticals

Skip to navigation
Skip to main content

March 28, 2019 Financing
Polyneuron raises CHF 22.5 million in a major Series A financing

Polyneuron raises CHF 22.5 million in an oversubscribed Series A financing to advance novel therapies for autoimmune diseases. Leading venture capital firm Sofinnova Partners led the Series A financing, together with New Enterprise Associates, which co-led the round Press Release… [read on]
May 15, 2018 Financing
Completion of financing and team strengthening

Polyneuron announces the completion of a CHF 3.1 million seed financing, following the receipt of a second tranche. Furthermore, the company’s management team and the board of directors have been strengthened. Press release… [read on]
May 11, 2016 Financing
Polyneuron completes seed financing round

Polyneuron announced it has completed a seed financing round raising over CHF 3 million with a group of private investors together with early investors such as the EVA Basel and the ZKB. Press_Release_Polyneuron_20160511… [read on]